Severe Acute Respiratory Syndrome by COVID-19: Clinical- Epidemiological Profile and Spatial Distribution of Deaths in the States of Brazil
10.15343/0104-7809.202246620635I
Keywords:
SARS-CoV-2. Mortality. Spatial Analysis.Abstract
Severe Acute Respiratory Syndrome (SARS) is a severe manifestation of COVID-19 infection that, in some cases, can result in death. In the current global epidemiological scenario, Brazil is the second country with highest number of deaths from the disease; thus, it is necessary to know the clinical and epidemiological characteristics of deaths and how they are spatially distributed across territories. Therefore, the objective was to describe the clinical and epidemiological characteristics and the spatial distribution of SARS deaths due to COVID-19 in the Brazilian federative units (states). This is a descriptive and ecological study of SARS deaths due to COVID-19 in Brazilian states, from March 2020 to June 2021, based on secondary data available on the openDataSUS database. Descriptive statistics were performed for the clinical-epidemiological variables and the monthly mortality rates were determined by state and thematic maps were made in QGIS software version 2.4.17. A total of 196,109 deaths were recorded in the investigated period, predominantly male, older, white, and low-educated. Among the clinical variables, cough, respiratory distress, dyspnea, and the presence of comorbidities stood out. A heterogeneous spatial distribution of deaths was observed, with rates ranging from 0.00 to 24.59 deaths/100,000 inhabitants, the highest rates were in the states of Rio de Janeiro, Amazonas, Ceara, Sergipe, Sao Paulo, and Pernambuco. These findings raise the need for investments on the part of public management and health systems and services in the most affected states, improvements in epidemiological surveillance, permanent health education, increased access to immunization and health prevention measures to control and monitor SARS caused by COVID-19.
Downloads
Download data is not yet available.
References
1. Paiva KM, Hillesheim D, Rech CR, Delevatti RS, Brown RVS, Gonzáles AL et al. Prevalência e fatores associados à SRAG por COVID-19 em adultos e idosos com doença cardiovascular crônica. Arq Bras Cardiol. 2021; 117(5): 968-975. https://doi.or. g/10.36660/abc.20200955
2. Custódio ACD, Ribas FV, Toledo LV, Carvalho CJD, Lima LM, Freitas BACD. Hospitalizations and mortality by severe acute respiratory syndrome: comparison between the pre-pandemic and pandemic periods. Rev Bras Epidemiol. 2021; 24: 1-15. https://doi.org/10.1590/1980-549720210052
3. Hui DSC, Zumla A. Severe acute respiratory syndrome: historical, epidemiologic, and clinical features. Infect Dis Clin North Am. 2019; 33 (4): 869-889. https://doi.org/10.1016/j.idc.2019.07.001
4. World Health Organization. Coronavirus (COVID-19) Dashboard [página na internet]. Acesso em 27 de fevereiro de 2022. https://covid19.who.int/
5. Pan American Health Organization. Geo-Hub COVID-19 - Information System for the Region of the Americas. Acesso em 27 de fevereiro de 2022. https://paho-covid19-response-who.hub.arcgis.com/.
6. Gomes DR, Souza RC, Oliveira UR, Mattos, MP, Aleluia IRS, Mapeli AM. Interiorização da COVID-19 no oeste da Bahia: perfil epidemiológico e análise espacial dos óbitos e casos confirmados. Ciênc. Saúde Colet. 2021; 26; 4665-4680. https:// doi.org/10.1590/1413-812320212610.11262021
7. Nasser MA, Calazans MO, Fegadolli C, Oliveira SBD, Rodrigues JDF, Costa RDC et al. Vulnerabilidade e resposta social à pandemia de Covid-19 em territórios metropolitanos de São Paulo e da Baixada Santista, SP, Brasil. Interface. 2021; (25): 1-18. https://doi.org/10.1590/interface.210125
8. Santos AA. Vulnerabilidades e seus impactos nos grupos humanos em tempos de covid-19 [Livro eletrônico]. Maceió: EDUFAL, 2021. Acesso em 12 de fevereiro de 2022. https://www.repositorio.ufal.br/bitstream/123456789/8035/1/ Vulnerabilidades%20e%20seus%20impactos%20nos%20grupos%20humanos%20em%20tempos%20de%20covid-19.pdf
9. Chen Y, Klein SL, Garibaldi BT, Li H, Wu C, Osevala NM et al. Aging in COVID-19: vulnerability, immunity and intervention. Ageing Res Ver. 2021; 65; 101205. https://doi.org/10.1016/j.arr.2020.101205
10. Albitar O, Ballouze R, Ooi JP, Ghadzi SMS. Risk factors for mortality among COVID-19 patients. Diabetes Res Clin Practice. 2020; 166; 108293. https://doi.org/10.1016/j.diabres.2020.108293.
11. Matias LDM, Lucena JGS, Azevedo TF, Silva ALDA, Costa MML, Andrade LL. Factors related to the prevention of covid-19 in people with diabetes: a cross-sectional study. Online Braz J Nurs. 2021; 20(1): e20216517. https://doi.org/10.17665/1676- 4285.20216517
12. Munazza F, Kara JO, Wenjia W, Arshad S, Gruebner O. Geospatial Analysis of COVID-19: A Scoping Review. Int. J. Environ Res Public Health. 2021; 18(5): 2336. https://doi.org/10.3390/ijerph18052336
13. Barbosa TP, Costa FBP, Ramos ACV, Berra TZ, Arroyo LH, Alves YM et al. Morbidade e mortalidade do COVID-19 associadas a doenças crônicas, serviços de saúde e iniquidades: evidência de sindemia. Rev Panam Salud Publica. 2022; 46; e6. https://doi.org/10.26633/RPSP.2022.6
14. Barbosa IR, Galvão MHR, Souza TA, Gomes SM, Medeiros AA, Lima KC. Incidence of and mortality from COVID-19 in the older Brazilian population and its relationship with contextual indicators: an ecological study. Rev Bras Geriatr Gerontol. 2020; 23(1): e200171. http://dx.doi.org/10.1590/1981-22562020023.200171.
15. Andrade LA, Paz WS, Lima AGCF, Araújo DC, Duque AM, Peixoto MVS, et al. Spatiotemporal pattern of covid-19-related mortality during the first year of the pandemic in Brazil: a population-based study in a region of high social vulnerability. Am J Trop Med Hyg. 2022; 106(1): 132-142. https://doi.org/10.4269/ajtmh.21-0744
16. BRASIL. Ministério da Saúde. Portaria n 1.631/GM, de 1o de outubro de 2015. Aprova critérios e parâmetros para o planejamento e programação de ações e serviços de saúde no âmbito do SUS. Brasília, 2015. https://bvsms.saude.gov.br/bvs/ saudelegis/gm/2015/prt1631_01_10_2015.html
17. Instituto Brasileiro de Geografia e Estatística. Divisão Regional do Brasil. Acesso em 24 de novembro de 2021. https://ibge. gov.br/geociencias/organizacao-do-territorio/divisao-regional/15778-divisoes-regionais-do-brasil.html?=&t=acesso-ao-produto
18. OPENDATASUS. Dados do CoranaVirus. Acesso em 24 de novembro de 2021. https://opendatasus.saude.gov.br/dataset/ srag-2021-e-2022
19. Instituto Brasileiro de Geografia e Estatística. Estimativas de População. Acesso em 24 de novembro de 2021. https://sidra. ibge.gov.br/pesquisa/EstimaPop/tabelas
20. Ministério da Saúde. COVID-19 no Brasil. Acesso em 24 de novembro de 2021. Disponível em: https://qsprod.saude.gov. br/extensions/covid-19_html/covid-19_html.html
21. Rosenthal N, Cao Z, Gundrum J, Sianis J, Safo S. Risk factors associated with in-hospital mortality in a US national sample of patients with COVID-19. JAMA Netw Open. 2020; 3(12): e2029058. https://doi.org/10.1001/jamannetworkopen.2020.29058
22. Berenguer J, Ryan P, Rodríguez-Baño J, Jarrín I, Carratalà J, Pachón J, et al. Characteristics and predictors of death among 4035 consecutively hospitalized patients with COVID-19 in Spain. Clin Microbiol Infect. 2020; 26(11): 1525–1536. https:// doi.org/10.1016/j.cmi.2020.07.024
23. Surendra H, Elyazar IR, Djaafara BA. Clinical characteristics and mortality associated with COVID-19 in Jakarta, Indonesia: A hospital-based retrospective cohort study. Lancet Reg Health West Pac. 2021; 9; 100-108. https://doi.org/10.1016/j. lanwpc.2021.100108
24. Sousa GJB, Garces TS, Cestari VRF, Florêncio R, Moreira T, Pereira M. Mortality and survival of COVID-19. Epidemiol Infect. 2020; 148; e123. https://doi.org/10.1017/s0950268820001405
25. De Negri F, Galiezz R, Miranda P et al. Socioeconomic factors and probability of death by Covid-19 in Brazil. J Public Health. 2021; 43 (3): 493-498. https://doi.org/10.1093/pubmed/fdaa279
26. Li SL, Pereira RHM, Prete Jr CA, Emanuel L, Alves PJ, Messina JP. Higher risk of death from COVID-19 in low-income and non-White populations of São Paulo, Brazil. BMJ Global Health 2021;6(4): e004959. http://dx.doi.org/10.1136/ bmjgh-2021-004959
27. Porto EF, Domingues AL, Souza AC, Miranda MKV, Froes MDC, Pasqualinoto SRV. Mortalidade por Covid-19 no Brasil: perfil sociodemográfico das primeiras semanas. Res Soc Dev. 2021; 10(1): e34210111588. http://dx.doi.org/10.33448/rsd-v10i1.XX
28. Gadi N, Wu S, Spihlman AP, Moulton VR. What’s sex got to do with COVID-19? Gender-based differences in the host immune response to coronaviruses. Front Immunol. 2020; 11:2147. https://doi.org/10.3389/fimmu.2020.02147
29. Gemmati D, Bramanti B, Serino ML, Secchiero P, Zauli G, Veronica T. COVID-19 and Susceptibility / Individual Genetic Receptivity: Role of ACE1 / ACE2 Genes, Immunity, Inflammation and Coagulation. Can the double X chromosome in women be protective against SARS-CoV-2 compared to the single X chromosome in men?. Int J Mol Sci. 2020; 21(10): 3474. https:// doi.org/10.3390/ijms21103474
30. Sharma G, Volgman AS, Michos ED. Sex differences in mortality from COVID-19 pandemic: are men vulnerable and women protected? JACC Case Rep . 2020; Acesso em 07 de fevereiro de 2022; 2(9): 1407–1410. https://doi.org/10.1016/j. jaccas.2020.04.027
31. Alshogran OY, Altawalbeh SM, Al-Azzam SI, Karasneh R. Predictors of COVID-19 case fatality rate: An ecological study. Ann Med Surg. 2021; 65; 102319. https://doi.org/10.1016/j.amsu.2021.102319
32. Zhang JJ, Cao YY, Tan G, Dong X, Wang BC, Lin J et al. Clinical, radiological and laboratory characteristics and risk factors for severity and mortality of 289 hospitalized COVID-19 patients. Allergy. 2020; 76(2): 533-550. https://doi.org/10.1111/ all.14496
33. Granda EC, Cunha SGS, Silva MF, Campos KFC. COVID-19 em idosos: por que eles são mais vulneráveis ao novo coronavírus?. Braz.J. Dev. 2021; 7; 42572-42581. https://doi.org/10.34117/bjdv7n4-630.
34. Promislow D. A geroscientific perspective on mortality from COVID-19. J. Gerontol [revista em internet]. 17 de abril de 2020; Acesso em 07 de fevereiro de 2022; 75 (9): e30–e33. https://doi.org/10.1093/gerona/glaa094.
35. Romero DE, Muzy J, Damacena GN, Souza NA, Almeida WS, Szwarcwald CL et al. Idosos no contexto da pandemia da COVID-19 no Brasil: efeitos nas condições de saúde, renda e trabalho. Cad Saude Publica. 2021; 37(3): e00216620. https:// doi.org/10.1590/0102-311x00216620
36. Benavides FG, Vives A, Zimmerman M, Silva-Peñaherrera M. Exceso de mortalidad en población en edad de trabajar en nueve países de Latinoamérica, año 2020. Rev Panam Salud Publica. 2022; 21(46): e75. https://doi.org/10.26633/rpsp.2022.75
37. Mascarello KC, Vieira ACBC, Souza ASS, Marcarini WD, Barauna VG, Maciel ELN. Hospitalização e morte por covid-19 e sua relação com determinantes sociais da saúde e morbidades no Espírito Santo: um estudo transversal. Epidemiol Serv Saude. 2021; 30(3) :e2020919. https://doi.org/10.1590/S1679-49742021000300004
38. Baqui P, Bica I, Marra V, Ercole A, van der Schaar M. Ethnic and regional variations in hospital mortality from COVID-19 in Brazil: a cross-sectional observational study. Lancet Glob Health. 2020; 8(8): e1018-e1026. https://doi.org/10.1016/S2214- 109X(20)30285
39. Araújo EM, Caldwell KL, Santos MPA, Souza IMP, Rosa PLFS, Santos ABS, et al Covid-19 - morbimortalidade pela COVID-19 segundo raça/cor/etnia: a experiência do Brasil e dos Estados Unidos. Saúde Debate. 2020;44(4):191-205. https:// doi.org/10.1590/0103-11042020E412.
40. Beiting KJ, Huisingh-Scheetz M, Walker J, Graupner J, Martinchek J, Thompson K et al. Management and outcomes of a COVID-19 outbreak in a nursing home with predominantly Black residents. J Am Geriatr Soc. 2021; 69; 1155–1165. https:// doi.org/10.1111/jgs.17126
41. Calbino D, Sabino G, Lima I. A trajetória dos movimentos negros pela educação: conquistas e desafios. Linhas Críticas. 2022; 28: e40739. https://doi.org/10.26512/lc28202240739.
42. Romero DE, Maia L, Muzy J. Tendência e desigualdade na completude da informação sobre raça/cor dos óbitos de idosos no sistema de informações sobre mortalidade no Brasil, entre 2000 e 2015. Cad Saúde Pública. 2019; 35(12): e00223218. https://doi.org/10.1590/0102-311X00223218.
43. Grasselli G, Greco M, Zanella A et al. Risk Factors associated with mortality among patients with covid-19 in intensive care units in Lombardy, Italy. JAMA Intern Med. 2020; 180(10): 1345-1355. http://doi.org/10.1001/jama.2020.4031
44. Ramos-Rincon JM, Buonaiuto V, Ricci M, Martín-Carmona J, Paredes-Ruíz D, Calderón-Moreno M et al. Clinical Characteristics and Risk Factors for Mortality in Very Old Patients Hospitalized With COVID-19 in Spain. J Gerontol A Biol Sci Med Sci. 2021; 76(3): e28-e37. https://doi.org/10.1093/gerona/glaa243
45. Han Y, Duan X, Yang L, Nilsson-Payant BE, Wang P, Duan F, et al. Identification of SARS-CoV-2 inhibitors using lung and colonic organoids. Nature [revista da internet]. 2021; 589(7841):270–275. https://doi.org/10.1038/s41586-020-2901-9 .
46. Mallipattu SK, Jawa R, Moffitt R et al. Geospatial Distribution and Predictors of Mortality in Hospitalized Patients With COVID-19: A Cohort Study. Open Forum Infect Dis. 2020;7(10): ofaa436. https://doi.org/10.1093/ofid/ofaa436.
47. Bonnet G, Weizman O, Trimaille A, Pommier T, Cellier J, Geneste, L. Characteristics and outcomes of patients hospitalized for COVID-19 in France: The critical COVID-19 France (CCF) study. Arch Cardiovasc Dis. 2021; 114(5): 352-363. https://doi. org/10.1016/j.acvd.2021.01.003
48. Muniyappa R, Gubbi S. COVID-19 pandemic, coronaviruses, and diabetes mellitus. Am J Physiol Endocrinol Metab. 2020; 318: e736-741. https://doi.org/10.1152/ajpendo.00124.2020.
49. Santos AM, Souza BF, Carvalho CA, Campos MAG, Oliveira BLCA, Diniz EM, et al. Excess deaths from all causes and by COVID-19 in Brazil in 2020. Rev Saúde Publica. 2021;55:71. https://doi.org/10.11606/s1518-8787.2021055004137.
50. França EB, Ishitani LH, Teixeira RA, et al. Óbitos por COVID-19 no Brasil: quantos e quais estamos identificando? Rev Bras Epidemiol 2020; 23:e200053. https://doi.org/10.1590/1980-549720200053
51. Fernandes GA, Junior APN, Azevedo e Silva G, Feriani D, França, Silva ILA et al. Excess mortality by specific causes of deaths in the city of São Paulo, Brazil, during the COVID-19 pandemic. Plos One. 2021;16(6): e0252238. https://doi. org/10.1371/journal.pone.0252238
52. Secretária de saúde governo do estado do Ceará. Boletim epidemiológico: doença pelo novo coronavírus (COVID-19) [página na internet]. Acesso em 08 de março de 2022. https://coronavirus.ceara.gov.br/project/boletim-epidemiologico-no- 28-de-02-de-junho-de-2020/
53. Pinheiro TMD, Oliveira ES, Morais ACLN. Tendências na incidência e mortalidade do SARS-COV-2 no Estado do Ceará: impacto das comorbidades. Rev. Casos e Consultoria . 2021;12(1): e23520. https://periodicos.ufrn.br/casoseconsultoria/ article/view/23520
54. Conselho Nacional de Saúde. Recomendação Nº 001 de 27 de janeiro de 2022. http://conselho.saude.gov.br/ recomendacoes-cns/2309-recomendacao-n-001-de-27-de-janeiro-de-2022.
55. Candido DS, Claro IM, Jesus JG, Souza WM, Moreira FR, Dellicour SE et al. Evolution and epidemic spread of SARS-CoV-2 in Brazil. Science. 2020; 369(6508): 1255-1260. https://doi.org/10.1126/science.abd2161
56. Silva GA, Jardim BC, Lotufo PA. Mortalidade por COVID-19 padronizada por idade nas capitais das diferentes regiões do Brasil. Cad. Saúde Pública. 2021; 37(6): e00039221. https://doi.org/10.1590/0102-311X00039221
57. Brasil. Ministério da Saúde. Plano Nacional de Operacionalização da Vacinação Contra a Covid-19. 11ª ed. Brasília, 2021. Acesso em 05 dez 2021. https://www.gov.br/saude/pt-br/coronavirus/publicacoes-tecnicas/guias-e-planos/plano-nacional-de-vacinacao-covid-19.
58. McNamara LA, Wiegand RE, Burke RM, Sharma AJ, Sheppard M, Adjemian J et al. Estimating the early impact of the US COVID-19 vaccination programme on COVID-19 cases, emergency department visits, hospital admissions, and deaths among adults aged 65 years and older: an ecological analysis of national surveillance data. Lancet. 2022;399(10320): 152-160. https://doi.org/10.1016/S0140-6736(21)02226-1 .
59. Rodrigues Júnior NS, Moreno SM, Machado MGO, Costa Filho AAI, Ibiapina ARS. Vacinação contra a COVID-19 em território nacional. Rev Enf Contemp. 2022;11: e4714. https://doi.org/10.17267/2317-3378rec.2022.e4714
60. Silva GA, Jardim BC, Lotufo PA. Mortalidade por COVID-19 padronizada por idade nas capitais das diferentes regiões do Brasil. Cad Saúde Pública. 2021; 37(6): e00039221. https://doi.org/10.1590/0102-311X00039221
61. Mendonça FD, Rocha SS, Pinheiro DLP, Oliveira SV. Região Norte do Brasil e a pandemia de COVID-19: análise socioeconômica e epidemiológica. J. Health NPEPS. 2020; 5(1):20-37. http://dx.doi.org/10.30681/252610104535
62. Secretária de Estado de Saúde do Rio Grande do Sul (SES-RS). Excesso de Óbitos e Taxa de Mortalidade no Brasil. Acesso em 08 de março de 2022. https://estado.rs.gov.br/upload/arquivos//excesso-de-obitos-rs-2021-06-23-v2.pdf.
63. Kerr L, Kendall C, Silva AAMD, Aquino EML, Pescarini JM, Almeida RLFD, et al. COVID-19 no Nordeste brasileiro: sucessos e limitações nas respostas dos governos dos estados. Cien Saude Colet. 2020; 25(2): 4099-4120. https://doi.org/10.1590/1413- 812320202510.2.28642020
64. Secretária do Estado de Saúde do Maranhão (SES-MA). Retrospectiva: Maranhão atravessa pandemia com a menor taxa de mortalidade por covid-19 do país [página em internet]. Acesso em 04 de janeiro de 2022. https://www.ma.gov.br/ agenciadenoticias/?p=328238
65. Orellana JDY, Cunha GM, Marrero L, Moreira RI, Leite IC, Horta BL. Excesso de mortes durante a pandemia de COVID-19: subnotificação e desigualdades regionais no Brasil. Cad Saúde Pública, 2021; 37(1): e00259120. https://doi.org/10.1590/0102- 311X00259120
66. Secretária do Estado de Saúde do Ceará (SES-CE). COVID-19. Acesso em 18 dez 2021. https://www.saude.ce.gov.br/ download/covid-19/
2. Custódio ACD, Ribas FV, Toledo LV, Carvalho CJD, Lima LM, Freitas BACD. Hospitalizations and mortality by severe acute respiratory syndrome: comparison between the pre-pandemic and pandemic periods. Rev Bras Epidemiol. 2021; 24: 1-15. https://doi.org/10.1590/1980-549720210052
3. Hui DSC, Zumla A. Severe acute respiratory syndrome: historical, epidemiologic, and clinical features. Infect Dis Clin North Am. 2019; 33 (4): 869-889. https://doi.org/10.1016/j.idc.2019.07.001
4. World Health Organization. Coronavirus (COVID-19) Dashboard [página na internet]. Acesso em 27 de fevereiro de 2022. https://covid19.who.int/
5. Pan American Health Organization. Geo-Hub COVID-19 - Information System for the Region of the Americas. Acesso em 27 de fevereiro de 2022. https://paho-covid19-response-who.hub.arcgis.com/.
6. Gomes DR, Souza RC, Oliveira UR, Mattos, MP, Aleluia IRS, Mapeli AM. Interiorização da COVID-19 no oeste da Bahia: perfil epidemiológico e análise espacial dos óbitos e casos confirmados. Ciênc. Saúde Colet. 2021; 26; 4665-4680. https:// doi.org/10.1590/1413-812320212610.11262021
7. Nasser MA, Calazans MO, Fegadolli C, Oliveira SBD, Rodrigues JDF, Costa RDC et al. Vulnerabilidade e resposta social à pandemia de Covid-19 em territórios metropolitanos de São Paulo e da Baixada Santista, SP, Brasil. Interface. 2021; (25): 1-18. https://doi.org/10.1590/interface.210125
8. Santos AA. Vulnerabilidades e seus impactos nos grupos humanos em tempos de covid-19 [Livro eletrônico]. Maceió: EDUFAL, 2021. Acesso em 12 de fevereiro de 2022. https://www.repositorio.ufal.br/bitstream/123456789/8035/1/ Vulnerabilidades%20e%20seus%20impactos%20nos%20grupos%20humanos%20em%20tempos%20de%20covid-19.pdf
9. Chen Y, Klein SL, Garibaldi BT, Li H, Wu C, Osevala NM et al. Aging in COVID-19: vulnerability, immunity and intervention. Ageing Res Ver. 2021; 65; 101205. https://doi.org/10.1016/j.arr.2020.101205
10. Albitar O, Ballouze R, Ooi JP, Ghadzi SMS. Risk factors for mortality among COVID-19 patients. Diabetes Res Clin Practice. 2020; 166; 108293. https://doi.org/10.1016/j.diabres.2020.108293.
11. Matias LDM, Lucena JGS, Azevedo TF, Silva ALDA, Costa MML, Andrade LL. Factors related to the prevention of covid-19 in people with diabetes: a cross-sectional study. Online Braz J Nurs. 2021; 20(1): e20216517. https://doi.org/10.17665/1676- 4285.20216517
12. Munazza F, Kara JO, Wenjia W, Arshad S, Gruebner O. Geospatial Analysis of COVID-19: A Scoping Review. Int. J. Environ Res Public Health. 2021; 18(5): 2336. https://doi.org/10.3390/ijerph18052336
13. Barbosa TP, Costa FBP, Ramos ACV, Berra TZ, Arroyo LH, Alves YM et al. Morbidade e mortalidade do COVID-19 associadas a doenças crônicas, serviços de saúde e iniquidades: evidência de sindemia. Rev Panam Salud Publica. 2022; 46; e6. https://doi.org/10.26633/RPSP.2022.6
14. Barbosa IR, Galvão MHR, Souza TA, Gomes SM, Medeiros AA, Lima KC. Incidence of and mortality from COVID-19 in the older Brazilian population and its relationship with contextual indicators: an ecological study. Rev Bras Geriatr Gerontol. 2020; 23(1): e200171. http://dx.doi.org/10.1590/1981-22562020023.200171.
15. Andrade LA, Paz WS, Lima AGCF, Araújo DC, Duque AM, Peixoto MVS, et al. Spatiotemporal pattern of covid-19-related mortality during the first year of the pandemic in Brazil: a population-based study in a region of high social vulnerability. Am J Trop Med Hyg. 2022; 106(1): 132-142. https://doi.org/10.4269/ajtmh.21-0744
16. BRASIL. Ministério da Saúde. Portaria n 1.631/GM, de 1o de outubro de 2015. Aprova critérios e parâmetros para o planejamento e programação de ações e serviços de saúde no âmbito do SUS. Brasília, 2015. https://bvsms.saude.gov.br/bvs/ saudelegis/gm/2015/prt1631_01_10_2015.html
17. Instituto Brasileiro de Geografia e Estatística. Divisão Regional do Brasil. Acesso em 24 de novembro de 2021. https://ibge. gov.br/geociencias/organizacao-do-territorio/divisao-regional/15778-divisoes-regionais-do-brasil.html?=&t=acesso-ao-produto
18. OPENDATASUS. Dados do CoranaVirus. Acesso em 24 de novembro de 2021. https://opendatasus.saude.gov.br/dataset/ srag-2021-e-2022
19. Instituto Brasileiro de Geografia e Estatística. Estimativas de População. Acesso em 24 de novembro de 2021. https://sidra. ibge.gov.br/pesquisa/EstimaPop/tabelas
20. Ministério da Saúde. COVID-19 no Brasil. Acesso em 24 de novembro de 2021. Disponível em: https://qsprod.saude.gov. br/extensions/covid-19_html/covid-19_html.html
21. Rosenthal N, Cao Z, Gundrum J, Sianis J, Safo S. Risk factors associated with in-hospital mortality in a US national sample of patients with COVID-19. JAMA Netw Open. 2020; 3(12): e2029058. https://doi.org/10.1001/jamannetworkopen.2020.29058
22. Berenguer J, Ryan P, Rodríguez-Baño J, Jarrín I, Carratalà J, Pachón J, et al. Characteristics and predictors of death among 4035 consecutively hospitalized patients with COVID-19 in Spain. Clin Microbiol Infect. 2020; 26(11): 1525–1536. https:// doi.org/10.1016/j.cmi.2020.07.024
23. Surendra H, Elyazar IR, Djaafara BA. Clinical characteristics and mortality associated with COVID-19 in Jakarta, Indonesia: A hospital-based retrospective cohort study. Lancet Reg Health West Pac. 2021; 9; 100-108. https://doi.org/10.1016/j. lanwpc.2021.100108
24. Sousa GJB, Garces TS, Cestari VRF, Florêncio R, Moreira T, Pereira M. Mortality and survival of COVID-19. Epidemiol Infect. 2020; 148; e123. https://doi.org/10.1017/s0950268820001405
25. De Negri F, Galiezz R, Miranda P et al. Socioeconomic factors and probability of death by Covid-19 in Brazil. J Public Health. 2021; 43 (3): 493-498. https://doi.org/10.1093/pubmed/fdaa279
26. Li SL, Pereira RHM, Prete Jr CA, Emanuel L, Alves PJ, Messina JP. Higher risk of death from COVID-19 in low-income and non-White populations of São Paulo, Brazil. BMJ Global Health 2021;6(4): e004959. http://dx.doi.org/10.1136/ bmjgh-2021-004959
27. Porto EF, Domingues AL, Souza AC, Miranda MKV, Froes MDC, Pasqualinoto SRV. Mortalidade por Covid-19 no Brasil: perfil sociodemográfico das primeiras semanas. Res Soc Dev. 2021; 10(1): e34210111588. http://dx.doi.org/10.33448/rsd-v10i1.XX
28. Gadi N, Wu S, Spihlman AP, Moulton VR. What’s sex got to do with COVID-19? Gender-based differences in the host immune response to coronaviruses. Front Immunol. 2020; 11:2147. https://doi.org/10.3389/fimmu.2020.02147
29. Gemmati D, Bramanti B, Serino ML, Secchiero P, Zauli G, Veronica T. COVID-19 and Susceptibility / Individual Genetic Receptivity: Role of ACE1 / ACE2 Genes, Immunity, Inflammation and Coagulation. Can the double X chromosome in women be protective against SARS-CoV-2 compared to the single X chromosome in men?. Int J Mol Sci. 2020; 21(10): 3474. https:// doi.org/10.3390/ijms21103474
30. Sharma G, Volgman AS, Michos ED. Sex differences in mortality from COVID-19 pandemic: are men vulnerable and women protected? JACC Case Rep . 2020; Acesso em 07 de fevereiro de 2022; 2(9): 1407–1410. https://doi.org/10.1016/j. jaccas.2020.04.027
31. Alshogran OY, Altawalbeh SM, Al-Azzam SI, Karasneh R. Predictors of COVID-19 case fatality rate: An ecological study. Ann Med Surg. 2021; 65; 102319. https://doi.org/10.1016/j.amsu.2021.102319
32. Zhang JJ, Cao YY, Tan G, Dong X, Wang BC, Lin J et al. Clinical, radiological and laboratory characteristics and risk factors for severity and mortality of 289 hospitalized COVID-19 patients. Allergy. 2020; 76(2): 533-550. https://doi.org/10.1111/ all.14496
33. Granda EC, Cunha SGS, Silva MF, Campos KFC. COVID-19 em idosos: por que eles são mais vulneráveis ao novo coronavírus?. Braz.J. Dev. 2021; 7; 42572-42581. https://doi.org/10.34117/bjdv7n4-630.
34. Promislow D. A geroscientific perspective on mortality from COVID-19. J. Gerontol [revista em internet]. 17 de abril de 2020; Acesso em 07 de fevereiro de 2022; 75 (9): e30–e33. https://doi.org/10.1093/gerona/glaa094.
35. Romero DE, Muzy J, Damacena GN, Souza NA, Almeida WS, Szwarcwald CL et al. Idosos no contexto da pandemia da COVID-19 no Brasil: efeitos nas condições de saúde, renda e trabalho. Cad Saude Publica. 2021; 37(3): e00216620. https:// doi.org/10.1590/0102-311x00216620
36. Benavides FG, Vives A, Zimmerman M, Silva-Peñaherrera M. Exceso de mortalidad en población en edad de trabajar en nueve países de Latinoamérica, año 2020. Rev Panam Salud Publica. 2022; 21(46): e75. https://doi.org/10.26633/rpsp.2022.75
37. Mascarello KC, Vieira ACBC, Souza ASS, Marcarini WD, Barauna VG, Maciel ELN. Hospitalização e morte por covid-19 e sua relação com determinantes sociais da saúde e morbidades no Espírito Santo: um estudo transversal. Epidemiol Serv Saude. 2021; 30(3) :e2020919. https://doi.org/10.1590/S1679-49742021000300004
38. Baqui P, Bica I, Marra V, Ercole A, van der Schaar M. Ethnic and regional variations in hospital mortality from COVID-19 in Brazil: a cross-sectional observational study. Lancet Glob Health. 2020; 8(8): e1018-e1026. https://doi.org/10.1016/S2214- 109X(20)30285
39. Araújo EM, Caldwell KL, Santos MPA, Souza IMP, Rosa PLFS, Santos ABS, et al Covid-19 - morbimortalidade pela COVID-19 segundo raça/cor/etnia: a experiência do Brasil e dos Estados Unidos. Saúde Debate. 2020;44(4):191-205. https:// doi.org/10.1590/0103-11042020E412.
40. Beiting KJ, Huisingh-Scheetz M, Walker J, Graupner J, Martinchek J, Thompson K et al. Management and outcomes of a COVID-19 outbreak in a nursing home with predominantly Black residents. J Am Geriatr Soc. 2021; 69; 1155–1165. https:// doi.org/10.1111/jgs.17126
41. Calbino D, Sabino G, Lima I. A trajetória dos movimentos negros pela educação: conquistas e desafios. Linhas Críticas. 2022; 28: e40739. https://doi.org/10.26512/lc28202240739.
42. Romero DE, Maia L, Muzy J. Tendência e desigualdade na completude da informação sobre raça/cor dos óbitos de idosos no sistema de informações sobre mortalidade no Brasil, entre 2000 e 2015. Cad Saúde Pública. 2019; 35(12): e00223218. https://doi.org/10.1590/0102-311X00223218.
43. Grasselli G, Greco M, Zanella A et al. Risk Factors associated with mortality among patients with covid-19 in intensive care units in Lombardy, Italy. JAMA Intern Med. 2020; 180(10): 1345-1355. http://doi.org/10.1001/jama.2020.4031
44. Ramos-Rincon JM, Buonaiuto V, Ricci M, Martín-Carmona J, Paredes-Ruíz D, Calderón-Moreno M et al. Clinical Characteristics and Risk Factors for Mortality in Very Old Patients Hospitalized With COVID-19 in Spain. J Gerontol A Biol Sci Med Sci. 2021; 76(3): e28-e37. https://doi.org/10.1093/gerona/glaa243
45. Han Y, Duan X, Yang L, Nilsson-Payant BE, Wang P, Duan F, et al. Identification of SARS-CoV-2 inhibitors using lung and colonic organoids. Nature [revista da internet]. 2021; 589(7841):270–275. https://doi.org/10.1038/s41586-020-2901-9 .
46. Mallipattu SK, Jawa R, Moffitt R et al. Geospatial Distribution and Predictors of Mortality in Hospitalized Patients With COVID-19: A Cohort Study. Open Forum Infect Dis. 2020;7(10): ofaa436. https://doi.org/10.1093/ofid/ofaa436.
47. Bonnet G, Weizman O, Trimaille A, Pommier T, Cellier J, Geneste, L. Characteristics and outcomes of patients hospitalized for COVID-19 in France: The critical COVID-19 France (CCF) study. Arch Cardiovasc Dis. 2021; 114(5): 352-363. https://doi. org/10.1016/j.acvd.2021.01.003
48. Muniyappa R, Gubbi S. COVID-19 pandemic, coronaviruses, and diabetes mellitus. Am J Physiol Endocrinol Metab. 2020; 318: e736-741. https://doi.org/10.1152/ajpendo.00124.2020.
49. Santos AM, Souza BF, Carvalho CA, Campos MAG, Oliveira BLCA, Diniz EM, et al. Excess deaths from all causes and by COVID-19 in Brazil in 2020. Rev Saúde Publica. 2021;55:71. https://doi.org/10.11606/s1518-8787.2021055004137.
50. França EB, Ishitani LH, Teixeira RA, et al. Óbitos por COVID-19 no Brasil: quantos e quais estamos identificando? Rev Bras Epidemiol 2020; 23:e200053. https://doi.org/10.1590/1980-549720200053
51. Fernandes GA, Junior APN, Azevedo e Silva G, Feriani D, França, Silva ILA et al. Excess mortality by specific causes of deaths in the city of São Paulo, Brazil, during the COVID-19 pandemic. Plos One. 2021;16(6): e0252238. https://doi. org/10.1371/journal.pone.0252238
52. Secretária de saúde governo do estado do Ceará. Boletim epidemiológico: doença pelo novo coronavírus (COVID-19) [página na internet]. Acesso em 08 de março de 2022. https://coronavirus.ceara.gov.br/project/boletim-epidemiologico-no- 28-de-02-de-junho-de-2020/
53. Pinheiro TMD, Oliveira ES, Morais ACLN. Tendências na incidência e mortalidade do SARS-COV-2 no Estado do Ceará: impacto das comorbidades. Rev. Casos e Consultoria . 2021;12(1): e23520. https://periodicos.ufrn.br/casoseconsultoria/ article/view/23520
54. Conselho Nacional de Saúde. Recomendação Nº 001 de 27 de janeiro de 2022. http://conselho.saude.gov.br/ recomendacoes-cns/2309-recomendacao-n-001-de-27-de-janeiro-de-2022.
55. Candido DS, Claro IM, Jesus JG, Souza WM, Moreira FR, Dellicour SE et al. Evolution and epidemic spread of SARS-CoV-2 in Brazil. Science. 2020; 369(6508): 1255-1260. https://doi.org/10.1126/science.abd2161
56. Silva GA, Jardim BC, Lotufo PA. Mortalidade por COVID-19 padronizada por idade nas capitais das diferentes regiões do Brasil. Cad. Saúde Pública. 2021; 37(6): e00039221. https://doi.org/10.1590/0102-311X00039221
57. Brasil. Ministério da Saúde. Plano Nacional de Operacionalização da Vacinação Contra a Covid-19. 11ª ed. Brasília, 2021. Acesso em 05 dez 2021. https://www.gov.br/saude/pt-br/coronavirus/publicacoes-tecnicas/guias-e-planos/plano-nacional-de-vacinacao-covid-19.
58. McNamara LA, Wiegand RE, Burke RM, Sharma AJ, Sheppard M, Adjemian J et al. Estimating the early impact of the US COVID-19 vaccination programme on COVID-19 cases, emergency department visits, hospital admissions, and deaths among adults aged 65 years and older: an ecological analysis of national surveillance data. Lancet. 2022;399(10320): 152-160. https://doi.org/10.1016/S0140-6736(21)02226-1 .
59. Rodrigues Júnior NS, Moreno SM, Machado MGO, Costa Filho AAI, Ibiapina ARS. Vacinação contra a COVID-19 em território nacional. Rev Enf Contemp. 2022;11: e4714. https://doi.org/10.17267/2317-3378rec.2022.e4714
60. Silva GA, Jardim BC, Lotufo PA. Mortalidade por COVID-19 padronizada por idade nas capitais das diferentes regiões do Brasil. Cad Saúde Pública. 2021; 37(6): e00039221. https://doi.org/10.1590/0102-311X00039221
61. Mendonça FD, Rocha SS, Pinheiro DLP, Oliveira SV. Região Norte do Brasil e a pandemia de COVID-19: análise socioeconômica e epidemiológica. J. Health NPEPS. 2020; 5(1):20-37. http://dx.doi.org/10.30681/252610104535
62. Secretária de Estado de Saúde do Rio Grande do Sul (SES-RS). Excesso de Óbitos e Taxa de Mortalidade no Brasil. Acesso em 08 de março de 2022. https://estado.rs.gov.br/upload/arquivos//excesso-de-obitos-rs-2021-06-23-v2.pdf.
63. Kerr L, Kendall C, Silva AAMD, Aquino EML, Pescarini JM, Almeida RLFD, et al. COVID-19 no Nordeste brasileiro: sucessos e limitações nas respostas dos governos dos estados. Cien Saude Colet. 2020; 25(2): 4099-4120. https://doi.org/10.1590/1413- 812320202510.2.28642020
64. Secretária do Estado de Saúde do Maranhão (SES-MA). Retrospectiva: Maranhão atravessa pandemia com a menor taxa de mortalidade por covid-19 do país [página em internet]. Acesso em 04 de janeiro de 2022. https://www.ma.gov.br/ agenciadenoticias/?p=328238
65. Orellana JDY, Cunha GM, Marrero L, Moreira RI, Leite IC, Horta BL. Excesso de mortes durante a pandemia de COVID-19: subnotificação e desigualdades regionais no Brasil. Cad Saúde Pública, 2021; 37(1): e00259120. https://doi.org/10.1590/0102- 311X00259120
66. Secretária do Estado de Saúde do Ceará (SES-CE). COVID-19. Acesso em 18 dez 2021. https://www.saude.ce.gov.br/ download/covid-19/
Downloads
Published
2022-12-20
How to Cite
Alves de Oliveira, R., Santos Neto, M., Maia Pascoal, L., Miranda Bezerra, J., Stabnow Santos, F., dos Santos Brito, P., & da Silva de Sousa, G. G. (2022). Severe Acute Respiratory Syndrome by COVID-19: Clinical- Epidemiological Profile and Spatial Distribution of Deaths in the States of Brazil: 10.15343/0104-7809.202246620635I. O Mundo Da Saúde, 46, 620–635. Retrieved from https://revistamundodasaude.emnuvens.com.br/mundodasaude/article/view/1464
Issue
Section
Articles
